{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:27:49Z","timestamp":1777865269837,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-030"],"award-info":[{"award-number":["2021-I2M-1-030"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330110"],"award-info":[{"award-number":["82330110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32141003"],"award-info":[{"award-number":["32141003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejmech.2024.116924","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T15:10:59Z","timestamp":1727536259000},"page":"116924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Design, synthesis, and bioactivity investigation of novel cyclic lipopeptide antibiotics targeting top-priority multidrug-resistant gram-negative bacteria"],"prefix":"10.1016","volume":"280","author":[{"given":"A-Long","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He-Xian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jiong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5748-7444","authenticated-orcid":false,"given":"Zhuo-Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116924_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2024.116924_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jare.2021.10.010","article-title":"Harnessing microbial iron chelators to develop innovative therapeutic agents","volume":"39","author":"Ribeiro","year":"2022","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejmech.2024.116924_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106899","article-title":"Synergy with farnesol rejuvenates colistin activity against Colistin-resistant Gram-negative bacteria in vitro and in vivo","volume":"62","author":"Han","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2024.116924_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.107033","article-title":"Intrathecal or intraventricular antimicrobial therapy for post-neurosurgical Gram-negative bacillary meningitis or ventriculitis: a systematic review and meta-analysis","volume":"63","author":"Li","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2024.116924_bib5","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/cid\/ciy378","volume":"67","author":"Kadri","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116924_bib7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/pharmrev.120.000020","article-title":"Rescuing the last-Line polymyxins: achievements and challenges","volume":"73","author":"Nang","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2024.116924_bib8","first-page":"723","article-title":"Agents of last resort: an update on polymyxin resistance","volume":"34","author":"Yang","year":"2020","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.ejmech.2024.116924_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijantimicag.2018.10.011","article-title":"Infections by multidrug-resistant Gram-negative bacteria: what's new in our arsenal and what's in the pipeline?","volume":"53","author":"Koulenti","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2024.116924_bib10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jinf.2012.01.015","article-title":"Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy","volume":"65","author":"Kubin","year":"2012","journal-title":"J. Infect."},{"key":"10.1016\/j.ejmech.2024.116924_bib11","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/cid\/cit453","article-title":"Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center","volume":"57","author":"Akajagbor","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116924_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jinf.2021.01.006","article-title":"Acute toxicity is a dose-limiting factor for intravenous polymyxin B: a safety and pharmacokinetic study in healthy Chinese subjects","volume":"82","author":"Liu","year":"2021","journal-title":"J. Infect."},{"key":"10.1016\/j.ejmech.2024.116924_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/160263a0","article-title":"Aerosporin, an antibiotic produced by Bacillus aerosporus Greer","volume":"159","author":"Ainsworth","year":"1947","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116924_bib14","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1039\/C7NP00023E","article-title":"Recent advances and perspectives in the design and development of polymyxins","volume":"34","author":"Rabanal","year":"2017","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2024.116924_bib15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-021-04264-x","article-title":"A naturally inspired antibiotic to target multidrug-resistant pathogens","volume":"601","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116924_bib16","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1021\/jm900999h","article-title":"Structure-activity relationships of polymyxin antibiotics","volume":"53","author":"Velkov","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116924_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-3-030-16373-0_4","article-title":"Polymyxins: mode of action","volume":"1145","author":"Li","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2024.116924_bib18","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1021\/jm991031b","article-title":"Solution structure of polymyxins B and E and effect of binding to lipopolysaccharide: an NMR and molecular modeling study","volume":"42","author":"Pristovsek","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116924_bib19","doi-asserted-by":"crossref","first-page":"13124","DOI":"10.1074\/jbc.M212364200","article-title":"Isolation, structural characterization, and properties of mattacin (polymyxin M), a cyclic peptide antibiotic produced by Paenibacillus kobensis M","volume":"278","author":"Martin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116924_bib20","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1021\/jp808379x","article-title":"Comparison of the structure and dynamics of the antibiotic peptide polymyxin B and the inactive nonapeptide in aqueous trifluoroethanol by NMR spectroscopy","volume":"113","author":"Meredith","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2024.116924_bib21","doi-asserted-by":"crossref","first-page":"11498","DOI":"10.1074\/jbc.M806587200","article-title":"Interactions of lipopolysaccharide and polymyxin studied by NMR spectroscopy","volume":"284","author":"Mares","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116924_bib22","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1021\/jm0000057","article-title":"Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria","volume":"43","author":"Tsubery","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116924_bib23","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1248\/cpb.55.1724","article-title":"Semi-synthesis of polymyxin B (2\u201310) and colistin (2\u201310) analogs employing the trichloroethoxycarbonyl (Troc) group for side chain protection of alpha,gamma-diaminobutyric acid residues","volume":"55","author":"Okimura","year":"2007","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejmech.2024.116924_bib24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1248\/cpb.57.240","article-title":"Contribution of each amino acid residue in polymyxin B(3) to antimicrobial and lipopolysaccharide binding activity","volume":"57","author":"Kanazawa","year":"2009","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejmech.2024.116924_bib25","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1021\/jm400416u","article-title":"Discovery of Dap-3 polymyxin analogues for the treatment of multidrug-resistant Gram-negative nosocomial infections","volume":"56","author":"Magee","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116924_bib26","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1021\/cb500080r","article-title":"Teaching \u2018old\u2019 polymyxins new tricks: new-generation lipopeptides targeting gram-negative \u2018superbugs\u2019","volume":"9","author":"Velkov","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116924_bib27","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1021\/acs.jmedchem.5b01593","article-title":"Activity and predicted nephrotoxicity of synthetic antibiotics based on polymyxin B","volume":"59","author":"Gallardo-Godoy","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116924_bib28","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2217\/fmb.13.39","article-title":"Pharmacology of polymyxins: new insights into an \u2018old\u2019 class of antibiotics","volume":"8","author":"Velkov","year":"2013","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ejmech.2024.116924_bib29","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1128\/AAC.01439-09","article-title":"A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane","volume":"54","author":"Vaara","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116924_bib30","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1021\/acsinfecdis.2c00307","article-title":"Polymyxin stereochemistry and its role in antibacterial activity and outer membrane disruption","volume":"8","author":"Slingerland","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116924_bib31","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1021\/acs.jmedchem.0c02217","article-title":"Total and semisyntheses of polymyxin analogues with 2-Thr or 10-Thr modifications to decipher the structure-activity relationship and improve the antibacterial activity","volume":"64","author":"Li","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116924_bib32","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1021\/acs.jmedchem.2c01915","article-title":"Critical role of position 10 residue in the polymyxin antimicrobial activity","volume":"66","author":"Patil","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116924_bib33","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1021\/acsinfecdis.9b00217","article-title":"Design of next generation polymyxins with lower toxicity: the discovery of spr206","volume":"5","author":"Brown","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116924_bib34","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/s41467-022-29234-3","article-title":"A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens","volume":"13","author":"Roberts","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116924_bib35","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3390\/antibiotics11121711","article-title":"Next-generation polymyxin class of antibiotics: a ray of hope illuminating a dark road","volume":"11","author":"Aslan","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ejmech.2024.116924_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bbamem.2015.11.011","article-title":"Tryptophan-containing lipopeptide antibiotics derived from polymyxin B with activity against gram positive and Gram negative bacteria","volume":"1858","author":"Grau-Campistany","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2024.116924_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/acsmedchemlett.7b00360","article-title":"Lysine analogue of polymyxin B as a significant opportunity for photodynamic antimicrobial chemotherapy","volume":"9","author":"Le Guern","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116924_bib38","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1021\/acs.jmedchem.7b01367","article-title":"Synthesis and bioactivity investigation of the individual components of cyclic lipopeptide antibiotics","volume":"61","author":"Cui","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116924_bib39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-3-030-16373-0_18","article-title":"Mechanisms of polymyxin-induced nephrotoxicity","volume":"1145","author":"Azad","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2024.116924_bib40","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1128\/AAC.01333-12","article-title":"Pharmacokinetics and renal disposition of polymyxin B in an animal model","volume":"56","author":"Abdelraouf","year":"2012","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424008055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424008055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:08:00Z","timestamp":1777529280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424008055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":39,"alternative-id":["S0223523424008055"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116924","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and bioactivity investigation of novel cyclic lipopeptide antibiotics targeting top-priority multidrug-resistant gram-negative bacteria","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116924"}}